Research led by by Raffaella Nativio, former research associate in the Berger Lab, Shelley Berger, Daniel S Och Professor and director of the Epigenetics Institute, and Nancy Bonini, professor of Biology, suggest that late-onset Alzheimer’s Disease is driven by epigenetic changes—how and when certain genes are turned on and off—in the brain. Results were published in Nature Genetics. The identification of this epigenetic process highlights potential drug treatment strategies for early-stage disease treatment. Please read the Penn Today article here.
Beth Harvey, a postdoc in the Granato Lab, and other National Institutes of Health (NIH) National Eye Institute (NEI)-funded scientists across the country are hacking the zebrafish’s innate regenerative capacity to learn how to treat human disease. Read more here. Congratulations, Beth!